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MECHANISMS  OF  LY2  SUPPRESSOR  CELL  ACTIVITY 
Activation of an Ly I  I-J  + Cell Is Required to Transduce the Suppressive 
Signal 
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The generation of suppression to sheep erythrocytes (SRBC) l in vitro involves 
the interaction of T  cell subsets in a well-defined regulatory circuit. The effector 
of this circuit  is an  Lyl-,2 + T  cell  (Ly2  cell)  that  has  the ability  to  suppress 
Lyl+,2 -  T  helper cells (Lyl cells) to make primary anti-SE plaque-forming cell 
(PFC) responses in culture. We have described biologically active antigen-specific 
cell-free products of Ly2 T  cells (Ly2 TsF) that can functionally mimic the action 
of the T  suppressor effector cell in vitro (1). This cell-free material, like the T 
suppressor effector cell, (a) can exert its suppressive effects early in the course 
of an in vitro immune response, in contrast to inducers of suppression, which 
require a long latency period before suppressive activity is expressed (2), and (b) 
does  not  express  any  I-J  or  other  I  region  major  histocompatibility complex 
(MHC)-controlled  specificities  that  can  be  detected  using a  large  battery  of 
antisera. This second finding is especially important in light of the fact that the 
biological  activity  of the  molecule is  restricted  by  genes  coded for  by  MHC 
polymorphisms expressed by suppressor acceptor cell partners (1). 
Previously we had thought that this molecule was produced by the terminal 
cell in the suppressor circuit, namely the Ly2 cell. Recently we found that by 
treating the Lyl  T  acceptor cell population with anti-I-J serum, we completely 
abrogated the ability of the Ly2 TsF to suppress the helper activity of these Lyl 
T  cells, while not affecting their ability to deliver help to T  cell-depleted spleen 
cells (B cells). The suppressive ability of the Ly2 TsF can be returned to cultures 
lacking I-J + Ly 1 cells by adding I-J + molecules recovered from immune Ly 1 cell- 
supernatants (3). In order for this I-J + material used to return suppressive activity 
to the Ly2 TsF, the donor of the I-J  + molecule had to match the I-J haplotype 
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of the cell that produced the Ly2 TsF and also had to match the Igh haplotype 
of the Lyl T  helper cell. 
These results suggested to us that two separate macromolecules are required 
for effecting suppression in  this system. The first molecule was supplied by an 
Ly2 cell,  and  can  act  alone  to suppress  Lyl  T  cell populations  by interacting 
with an Lyl I-J  + cell that "transduces" the signal to its final target cell, an Lyl I- 
J- T  helper cell, presumably by secreting an I-J  + molecule that can interact with 
the Ly2 TsF. We tested this hypothesis in a 48-h intermediate culture system by 
adding  Ly2  TsF  to  cultures  of spleen  cells  and  subsequently  assaying  this 
supernatant  for the presence of the  I-J  + molecule required  by the Ly2 TsF to 
effect suppression on I-J- Lyl T  cells. We report here that this I-J  + molecule can 
be directly induced  by the action of the  Ly2 TsF and  antigen  on  I-J  ÷,  Lyl  T 
cells in vitro.  Further,  the molecule induced shares all the characteristics of the 
I-J  + molecule found earlier in Lyl TsiF: (a) it does not bind to antigen or to anti- 
immunoglobulin reagents; (b) it does not depend on the immunizing antigen; (c) 
cells that  produce this  I-J  + material  must match  the cells that produce the Ly2 
TsF  at  MHC  and  the  target  cell  at  Igh  for  activity;  and  (d)  it  requires  for 
production an Lyl, I-J  + T  cell. We also found that successful induction of the I- 
J+ molecules by Ly2 TsF requires (a) an Ia  +, Ig- accessory cell, (b) antigen, and 
(c) homology at MHC between the cells that produce the Ly2 TsF and the cells 
that produce the I-J  + molecule. 
These results indicate that the Ly2 TsF can function as a one-chain suppressor 
molecule only insofar as it can induce the production of a  "partner" molecule, a 
molecule that  works in  tandem  with the  Ly2 TsF to effect suppression on the 
Lyl + T  helper cell. It also raises the possibility that a single molecular entity can 
be both an inducer molecule and a suppressor molecule, depending on the cell 
with which it interacts. 
Materials and Methods 
Mice.  C57BL/6, BALB/c, B10.D2, B10.BR, B10.A, and C57BL/10J mice, 6-10 wk 
of age, were obtained from The Jackson Laboratory, Bar Harbor, ME.  C.B20,  B.C9, 
BAB.14, B10.A(2R),  B10.A(3R),  B10.A(4R), and B10.A(SR) were bred and maintained 
at Yale University School of Medicine. 
Antisera and  Antigens.  Monoclonal  anti-Ly  sera were generously supplied  by F.  W. 
Shen,  Memorial  Sloan-Kettering  Cancer  Center,  New  York.  Monocional  anti-Thy-1 
reagents were generously provided by Dr. Jonathan Sprent, University  of Pennsylvania, 
b  Philadelphia,  PA.  Monoclonal  anti-I-A  reagents were provided by Dr.  C. A. Janeway, 
Yale University School of Medicine.  Anti-I-J  D  serum was prepared by hyperimmunizing 
B 10.A(5R) recipients  with a mixture of B10.A(3R) spleen and lymph node cells (antisera 
No. ASM-5 and ASM-20). Anti-I-J  k was prepared by hyperimmunizing  B 10.A(3R) recip- 
ients with a mixture of B 10.A(SR) spleen and lymph node cells (antiserum  ASM-18). (We 
thank  Dr.  D.  B.  Murphy  for preparing  these antisera).  Goat anti-mouse  Ig sera was 
prepared  by immunization  with  1 mg of an  equal mixture  of five different myeloma 
proteins  (MOPC  104E  (IgM,K),  TEPC15  (IgA,K),  MOPC  141  (IgG2b,K),  MOPC  21 
(IgG1 ,K), and RPC5 (IgG2a,K) in a total of 2 ml complete Freund's adjuvant containing 
Mycobacterium tuberculosis H37Ra  (Difco  Laboratories  Inc.,  Detroit,  MI)  in  two  sites 
subcutaneously.  Goats were boosted with the same mixed myeloma solution emulsified in 
incomplete Freund's adjuvant and bled starting 1 wk later.  Depletion of cells bearing Lyt 
or I-J markers was achieved by incubating  1  x  107  cells/ml of antibody appropriately 
diluted in balanced salt solution (BSS) (1:100 for anti-Ly monoclonal  antibody,  1:5 for FLOOD  AND  LOUIE  1415 
anti-Thy-1  monoclonal antibody hybridoma supernatant, or  1:10  for anti-I-J serum), 
washing, and incubating with complement for 45 min at 37°C (1 x  107 celis/ml of rabbit 
serum diluted 1  : 10 for anti-Ly, anti-I-A, or anti-I-J antibody or 1 ×  107 cell/ml of guinea 
pig complement for anti-Thy-1 antibody). Complement used in these experiments was 
serum from animals selected for low natural cytotoxicity to mouse spleen cells. Sheep, 
horse, and burro erythrocytes were obtained from Colorado Serum Company Laborato- 
ries, Denver, CO. 
Method of Cell Preparation.  Spleen cells were washed in BSS and suspended in RPMI 
1640 supplemented with antibiotics, 10% fetal calf serum (FCS),  100 mM glutamine, 25 
mM Hepes, and 5 x  10 -s M 2-mercaptoethanol for tissue culture. T  cells were prepared 
by the glass bead method of WigzeU (5). B cells were prepared by treating the cells with 
monoclonal anti-Thy-1 and complement. 
Preparation of Lyt-I+-Derived and Lyt-2+-Derived Suppressor Materials.  Preparation of 
Ly  1 TsiF and Ly2 TsF has been previously described (1, 2). Briefly, a suspension of spleen 
cells from mice hyperimmunized with RBC was treated with anti-Lyt-2 (for Lyl TsiF) or 
anti-Lyt-1 (for Ly2 TsF) and rabbit complement, and subsequently cultivated in vitro for 
48  h  in  RPMI  1640  plus  10%  FCS at a  concentration of 107  cells/ml.  After 48  h, 
supernatant fluids were cleared and passed through Miilipore filters (Milex filters, Milli- 
7  pore Corp., Bedford, MA). In primary cultures, cells at 10  cells/ml were incubated for 
48 h with antigen and Ly2 TsF added at a final dilution of 1:5. Supernatants were then 
cleared and passed through a Millipore filter before subsequent treatment. 
Absorption of Soluble Factors.  Absorption with erythrocytes was done by mixing 1 ml of 
culture supernatants with 0.1 ml of a 50% suspension of erythrocytes for 1 h on ice. The 
erythrocytes were removed by centrifugation. For absorption with anti-I-J or anti-mouse 
Ig sera, supernatant fluids were passed over the appropriate immunosorbent prepared by 
conjugation of antisera to cyanogen bromide-activated Sepharose. 
Assay Cultures.  Suppressor activity of the Ly  I TsiF or the Ly2 TsF was determined by 
adding these materials to cultures of unprimed spleen cells that had been treated with 
various test reagents. All ceils were suspended in culture medium, at a concentration of 2 
X  10 6 T  cells and 2 x  10  6 B cells in  1 ml, and cultured with 0.05  ml of a  1%  SRBC 
suspension in  Falcon 3008  plates (Falcon Labware, Div.  of Becton,  Dickinson & Co., 
Oxnard, CA) in a 5% COF95% air incubator at 37°C. The number of plaque-forming 
cells (PFC)  were determined on day 5 by using the Cunningham modification of the 
Jerne-Nordin plaque assay as previously described (6). Results are given as the mean of 
three individual calculations from each culture condition. 
Isolation ofl-J + Material.  Supernatants containing Lyl TsiF or from primary Lyl T 
cell cultures were passed over the appropriate immunosorbent column made from anti- 
I-J antisera coupled to Sepharose 4B.  After extensive washing, the column was eluted 
with 0.2 M sodium carbonate (Na~COs) pH  11.0.  The eluted material was concentrated 
to original volume, and dialyzed overnight against first phosphate-buffered saline (PBS), 
then RPMI 1640. 
Results 
An Lyl 1-J  + Cell Needed for Ly2 TsF Activity Can Be Replaced by Supernatant from 
a 48-h  Culture  of Spleen  Cells, Ly2  TsF,  and Antigen.  Addition of supernatants 
from  immune  Ly2  cells  had  significant  suppressive  activity  when  added  to 
cultures of Ly  1 T  cells and B cells (Table I, line 1). Removal of I-J  + Ly  1 T  cells 
from  the  assay culture,  while  not affecting the  PFC  response,  eliminated the 
ability of Ly2  TsF  to  suppress  these  cultures  (line  2).  Suppressive  activity is 
returned by the addition of an I-J  + molecule secreted by SRBC-primed Ly 1 T 
cells (line  3).  We investigated whether we could generate this I-J  + molecule in 
vitro in 48-h primary cultures of spleen cells. Supernatants of primary cultures 
to which nothing was added did not restore the suppressive activity of Ly2 TsF 
in the assay culture (line 4). Addition of Ly2 TsF to the primary culture did not 1416  INTERACTIONS IN  LY2  CELL-MEDIATED SUPPRESSION 
TABLE  I 
Addition of Supernatant from B6 Ly-1 T Cells Incubated with B6 Ly-2 TsF and SRBC Allows 
Ly-2 TsF to Suppress B6 Assay Cultures Depleted of I-J  + Ly-1 T Cells 
Group  Assay cells*  Cells added 
no. 
Primary culture*  Anti-SRBC PFC/culture I 
Ly2TsF  SRBC  !  Without 
added  0  added  Ly2TsF  With Ly2TsF 
1  LylT + B  --  -  -  2,800  700 
2  Lyl I-J-T + B  --  -  -  3,200  2,600 
3  LylI-J-T + B  Primed  -  -  3,500  500 
4  LylI-J-T + B  Naive  -  -  2,800  3,400 
5  LylI-J-T + B  Naive  +  -  3,100  2,800 
6  LylI-J-T + B  Naive  -  +  2,800  2,900 
7  Lyl I-J-T +  B  Naive  +  +  2,200  900 
* Assay cultures contained  Wigzell column-purified cells as a source of T  cells and anti-Thy-1- 
treated spleen cells as a source of B cells as detailed in Materials and Methods. Culture supernatant 
from primary cultures were added at a final concentration of 1:2 to assay cultures on day 0. 
* Primary cultures contained  107 SRBC-primed or naive B6 spleen cells. 
SRBC-specific Ly2 TsF was added at a final concentration of 1:5 at the initiation of primary culture. 
! 2 x  108 SRBC were added to the initiation of primary in vitro cultures. 
Primary in vitro response to SRBC. Numbers given in boldface type indicate cultures that showed 
>50% suppression upon addition of TsF. 
significantly increase  the  ability of this  supernatant  to replace the  need  for an 
I-J  +  cell  in  the  assay  culture  (line  5).  Likewise,  addition  of antigen  to  these 
cultures  had no effect on the  ability to generate this  I-J  + cell-replacing activity 
(line 6).  However, addition  of both  Ly2 TsF and  SRBC to primary cultures  of 
normal B6 spleen cells generated a supernatant that, when added to assay cultures 
of Lyl I-J- T  +  B cells and Ly2 TsF, resulted in suppression (line 7). Therefore, 
it  appears  that  the  Ly2  TsF  can  induce  the  production  of a  molecule  that 
functionally substitutes for an Lyl  I-J  + cell, and that this induction  requires the 
presence of antigen in the primary culture. 
Co-suppressive Activity in Primary Culture Supernatants (Which Allows Ly2 TsF to 
Suppress Assay Cultures Depleted  of I-J + Lyl Cells) Is Mediated by a Molecule  That Is 
Ig-, I-J +, and Antigen Nonspecific.  We investigated the supernatant that replaces 
the need for an Lyl  I-J  + cell in Ly2 cell-mediated suppression to determine the 
molecular  nature  of  this  activity.  Supernatants  from  normal  B6  spleen  cells 
induced by Ly2 TsF and antigen were passed over a  goat anti-mouse Ig column 
and the filtrate and eluate were assayed for their ability to complement Ly2 TsF 
in the suppression of Lyl  I-J- T  plus B cells (Table II). Our results clearly show 
that while Ly2 TsF in secondary culture  failed to suppress the response of Lyl 
I-J- T  plus B ceils (lines  1 and 2), addition of primary supernatant induced with 
Ly2 TsF replaces suppressive activity (line  3).  It is the  Ig- column filtrate, and 
not the Ig  + column eluate, that contains the relevant activity (lines 4  +  5). 
This supernatant  was then  passed over an anti-I-J immunosorbent  to deter- 
mine whether the molecule induced by the Ly2 TsF is I-J  +. Passage ofsupernatant 
over an anti-I-J  b immunosorbent  indicates  that  the  molecule that  replaces  the 
need for the I-J  + cell in the assay culture exhibits the I-J  b haplotype marker (lines 
6  and  7).  Passage  of the  same  supernatant  over an  anti-I-J  k  immunosorbent 
resulted in no activity being retained in the column (lines 8 and 9). In addition, FLOOD  AND  LOUIE  1417 
TABLE  II 
Activity in Supernatants of Ly-I T Cells Induced by Ly-2 TsF and SRBC That Assists Ly-2 TsF 
in Suppressing Cultures Depleted of I-j- Ly-I Cells is I-J + and Antigen Non-binding 
Donor of 
Ly-2 TsF  Treatment of primary cul-  Ly-2 TsF  Anti-SRBC 
Group  in pri-  in assay  PFC/cul-  Suppression 
mary cul-  ture supernatant  culturel  ture  I 
ture* 
1  -  --  --  2,800  Standard 
2  -  --  B6  3,200  - 
3  B6  --  B6  600  + 
4  B6  G-anti Mlg filtrate*  B6  1,200  + 
5  B6  G-anti MIg eluate  B6  3,400  - 
6  B6  Anti-I-J  b filtrate  B6  2,800  - 
7  B6  Anti-I-J  b eluate  B6  900  + 
8  B6  Anti-I-J  k filtrate  B6  1,200  + 
9  B6  Anti-I-J  k eluate  B6  3,100  - 
10  B6  SRBC absorbed  B6  800  + 
* See footnote*, table I. 
* G anti-Mlg columns have previously been shown to remove >95% of the Ig  + material from normal 
mouse serum by ELISA assay. Anti-I-J  b and anti I-J  k columns have previously been shown to remove 
95% of suppressive activity of an I-J  + Lyl TsiF from B6 or B10.BR mice, respectively. 
Ly2 TsF was added at a  final concentration of 1:5. 
I Assay cultures were all B6 Thy-l-depleted  spleen cells, B6 Lyl+,2  -  I-J- T  cells, and SRBC. 
absorption  of supernatant with the antigen used to induce the I-J + chain that 
removes the Ly2 TsF from the primary culture supernatant, reveals that the I- 
J+ molecule does not bind antigen (line 10). 
Our results indicate that while the I-J  + molecule induced by the Ly2 TsF does 
not bind antigen, antigen is required in the primary culture in order for Ly2 
TsF to induce this molecule. Therefore, we determined whether the I-J + mole- 
cule induced was restricted in its activity to the antigenic specificity of the TsF 
used to induce it. We did a  series of experiments making hybrid complexes of 
Ly2  TsF  and  I-J +  molecules that  were raised  against  different heterologous 
erythrocyte  specificities.  The  I-J +  molecule  was  induced  by  either  SRBC-, 
HRBC-, or BRBC-specific TsF in the primary culture and subsequently absorbed 
with the appropriate antigen. The results of these experiments are presented in 
Table III. Whether the I-J + molecule was induced by SRBC-, HRBC-, or BRBC- 
specific TsF, this supernatant could work with either the SRBC- or the HRBC- 
specific  Ly2  TsF  to  effect suppression.  Such  immunosuppressive  complexes 
exhibited the antigen specificity of the Ly2 TsF used in the assay culture, not 
the one used to induce this molecule in the primary culture. 
Cellular Requirements  That Allow Induction of l-J + Material by Ly2 TsF: Successful 
Induction  Requires Both  an I-A + and  an Lyl  I-J + Cell  in the Primary Culture.  We 
investigated the nature of the cells required for Ly2 TsF and antigen to induce 
the production of I-J  + molecule (Table IV), Normal B6 spleen cells were depleted 
of various subsets of cells and assayed for the ability to produce I-J + material in 
a primary culture after exposure to Ly2 TsF and antigen. Our results indicate 
that while Ig  + and Ly2  ÷ cells are not required for the induction of I-J  ÷ material, 
cells bearing I-A, I-J, Thy-1, and Lyt-1 markers are required for the induction 1418  INTERACTIONS  IN  LY2  CELL-MEDIATED  SUPPRESSION 
TABLE  III 
LJ  +  Material Induced by Ly-2 TsF is Antigen Nonspecific 
Ly-2 TsF in pri-  Ly-2 TsF in assay  Anti-SRBC  Anti-HRBC 
mary culture*  culture*  PFC/cultureJ  PFC/culture I 
--  --  3,600  1,000 
--  SRBC  ~  3,400  900 
--  HRBC  3,100  950 
SRBC  --  3,400  1,200 
SRBC  1,200  800 
HRBC  2,900  400 
HRBC 
BRBC 
--  3,500  1,100 
SRBC  1,700  900 
HRBC  3,000  300 
--  4,300  1,400 
SRBC  2,100  1,100 
HRBC  3,900  500 
* Primary cultures were naive B6 Lyl÷,2  -  T  cells incubated with appropriate Ly2 TsF diluted 1:5 
specificity, and homologous erythrocytes for 48 h. Supernatant was then harvested, absorbed with 
the immunizing antigen, and added to assay cultures at a final dilution of 1:2. 
* Assay cultures were  B6 spleen cells depleted of Thy-1  cells,  B6  Lyl+,2 -  I-J- T  cells,  Ly2  TsF 
diluted 1:10, and the appropriate antigen. 
Primary in vitro response of B6 mice to SRBC. 
! Primary in vitro response of B6 mice to HRBC. 
Antigen used to immunize B6 mice to produce factor. 
TABLE  IV 
Cellular Requirements That Allow the Induction of I-J +  Material by Ly2 TsF 
Anti SRBC PFC/culture* 
Treatment of cellular 
Group  source of I-J  + material*  Without  With 
Ly2 TsF  Ly2 TsF 
1  No I-J  + material  1,900  1,600 
2  None  1,700  300 
3  Ig  ÷ cell-depleted  1,700  600 
4  Anti-Thy-1 treated  1,800  1,700 
5  Anti-Lyl treated  2,000  1,800 
6  Anti-Ly2 treated  2,200  500 
7  Anti-I-J  b treated  1,800  2,000 
8  Anti-I-A  b treated  1,700  1,700 
9  Groups 5 and 70  1,800  2,000 
10  Groups 5 and 8  2,200  500 
11  Groups 7 and 8  1,700  600 
* 1.5 x  107 cells were treated with various antisera and incubated for 48 h with SRBC and Ly2 TsF 
diluted  1:5.  Supernatants were then harvested, cleared,  and absorbed with SRBC before being 
added to assay cultures. 
* See footnote *, Table I. 
0 Cells from groups 5 and 7, 5 and 8, or 7 and 8  were treated with antisera and complement and 
mixed before primary culture with Ly2 TsF and antigen. FLOOD  AND  LOUIE  1419 
event. We then mixed various cell populations after negative selection to deter- 
mine whether all  these markers were on  the same set of cells.  Groups  8-10 
indicate that while Lyl and I-J markers are on the same cell types, IA markers 
define a different cell subset that is also required for the induction event to take 
place. 
Genetic Requirements  That Allow Induction  of 1-J  + Material  by Ly2 TsF: Ly2 TsF 
Must Match Cells That Produce the I-J + Material at the IE Subregion of the MHC-linked 
Polymorphisms for Induction  to Occur.  Since  Ly2 TsF  must match the cell that 
produced the I-J  + molecule at the I-J subregion of the MHC in order for the 
functional molecular complex of Ly2 TsF and I-J + material to suppress Lyl I-J- 
T  plus B cells, we investigated the genetic restrictions involved in the induction 
of the  I-J  + molecule by  Ly2  TsF.  To  do  this  Lyl  cells from  B6  mice  were 
cocultured with a battery of Ly2 TsF produced in MHC and Igh congenic mice. 
The resulting supernatants were then absorbed with antigen and assayed for the 
presence of I-J + material on B6 cultures of Ly 1 I-J- T  plus B cells by the addition 
of syngeneic Ly2 TsF. The results in Table V show that successful induction of 
the I-J + molecule by Ly2 TsF requires MHC homology between the cells that 
produce the Ly2 TsF, and cells that produce the I-J  + material. 
We went further to localize the genetic homology requirements between the 
Ly2 TsF  and  the induced cell population  within the  MHC.  Ly2 TsF  from a 
variety of MHC recombinant mice were used to induce I-J + material from B 10.BR 
Lyl T  cells (Table VI). It was found that successful induction required genetic 
TABLE  V 
Genetic Requirements That Allow the Induction of LJ  + Material by Ly2 TsF: Ly2 TsF Must 
Match Cells That Produce the I-J +  Material at MHC for Functional Activity 
Identity of Ly2 TsF with 
Ly2 TsF in pri-  B6 cells in primary cul-  Ly2 TsF in 
mary culture**  ture  assay culture* 
Anti-SRBC PFC/culture| 
H-2  Igh  I  II 
--  --  3,300  3,400 
--  B6  2,600  4,200 
B6  +  +  B6  1,100  1,100 
B.C9  +  -  B6  1,000  1,200 
C.B20  -  +  B6  2,800  3,500 
BALB/c  -  -  B6  2,800  3,600 
BALB.B  +  -  B6  1,400  ND  ! 
B10.D2  -  +  B6  3,000  ND 
BALB.K  -  -  B6  2,600  ND 
B10.BR  -  +  B6  2,700  ND 
* The I-J  + material was obtained by incubating Lyl+,2  - T  cells from B6 mice with the indicated Ly2 
TsF diluted  1:5 for 48  h  as described and subsequently absorbing the supernatant with antigen 
before adding to the assay culture. 
* SRBC-specific. 
0 Results are from assay  cultures that contained 2  x  106  Lyl+,2  -  I-J- T  cells, 2  ×  106 anti-Thy- 
treated spleen cells, Ly2 TsF diluted  1:10,  supernatant from primary cultures diluted  1:2,  and 
SRBC.  Boldface numbers represent cultures that showed significant suppression (>50%) of the 
PFC response. 1 and//represent results from independent experiments. 
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TABLE  VI 
Genetic Requirements That Allow the Induction of I-J  +  Material by Ly2TsF: Ly2TsF Must Match 
Cells That Produce the I-J  +  Material at the IE Subregwn of the MHC for Functional Activity 
MHC Identity of Ly2TsF 
Ly2TsF in primary  with B10.BR cells in  Ly2TsF in  Anti-SRBC Suppres- 
culture**  primary culture  assay culture  PFC]culture  ~  sion  I 
--  K  A  J  E  C  D  --  4,300 
--  BI 0.BR  4,100  - 
BI0.BR  +  +  +  +  +  +  BI0.BR  1,I00  + 
B10  B10.BR  3,200  - 
BI0,A  +  +  +  +  BI0.BR  1,400  + 
B10.A(2R)  +  +  +  +  BI0.BR  700  + 
B 10.A(3R)  +  B 10,BR  1,800  + 
B10.A(4R)  +  +  BI0.BR  3,400  - 
B10.A(5R)  +  +  B10.BR  800  + 
* The I-J  + material was obtained by incubating Lyl+,2  - T cells from B10.BR mice with the indicated 
Ly2TsF diluted 1:5 for 48 h as described and subsequently absorbing the supernatant with antigen 
before adding to assay culture. 
* SRBC-specific. 
0 Results are from B6 assay cultures that contained T cells, B cells, B10.BR Ly2TsF diluted I:10, 
supernatants  from  primary  cultures  diluted  1:2, and  SRBC as  described.  Boldface numbers 
represent cultures that showed significant suppression. 
T  Cultures that showed >50% reduction in the PFC response were deemed positive for suppression. 
homology between the Ly2 TsF and the cells producing the I-J  + material at the 
IE subregion of the MHC. 
In every case where this criteria is not met, there is no detectable biologically 
active I-J  + material found in the 48-h culture supernatant. 
Genetic Requirements  That Allow Lyl I-J  +  Material Induced by Ly2 TsF to Assist Ly2 
TsF in Suppressing B6 Assay Cells Depleted of l-J ÷ Lyl Cells; I-J + Material Must Match 
Ly2 TsF at H-2 and Acceptor Cells at Igh-linked  Polymorphisms for Functional  Activ- 
ity.  Previous results  (3)  have shown  that  in  order for the  I-J  + molecule from 
Lyl  TsiF to work  in  consort with  the  Ly2 TsF  to suppress  Lyl  I-J-  T  plus  B 
cells,  the  cell  that  secretes  the  I-J  +  molecule  had  to:  (a)  match  the  cell  that 
secreted the Ly2 TsF at MHC-linked polymorphisms; and (b) match the acceptor 
cell population at Igh-linked polymorphisms.  We investigated whether the I-J  + 
molecule induced by the Ly2 TsF in the preculture behaved in a similar fashion. 
The results  of two separate  experiments of this  type are  given  in  Table  VII. 
These results indicate that only three combinations of Ly2 TsF and I-J  + material 
were able  to suppress  B6  Lyl  T  cells that  lacked  I-J  + cells.  The first was  the 
syngeneic mixture (B6 (H-2  b, Igh  b) I-J  + piece together with B6 Ly2 TsF on B6 
cells). In keeping with our earlier findings, C.B20 (H-2  d, Igh  b) I-J  + pieced together 
with  BALB/c  (H-2  a,  Igh  a)  Ly2 TsF  could suppress  B6 cells while  the  reverse, 
B.C9 I-J  + pieced with B6 Ly2 TsF, could not.  In addition, B10.D2 (H-2  d,  Igh  b) 
I-J  + material plus BALB/c Ly2 TsF, derived from strains that match each other 
only at the  MHC,  worked perfectly well  in  suppressing  B6  spleen cells,  which 
matches B10.D2 at Igh-V. The mapping of the Igh restriction to the interaction 
of acceptor cells and the I-J  + material was strengthened by the observation that 
C.B20 I-J  + material plus BALB/c  Ly2 TsF worked in restoring suppression  on FLOOD  AND  LOUIE 
TABLE  VII 
I-J + Molecule Induced by Ly-2 TsF Must Match Ly-2 TsF at H-2 and Acceptor Cells 
at Igh-linked Polymorphisms for Functional Activity 
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Strain source of I-J  +  Ly-2 TsF in  Anti-SRBC  PFC/culture! 
molecules**  assay culture  B6  B.C9 
--  --  4,300  1,800 
--  B6  3,900  1,900 
--  BALB/c  3,800  2,100 
B6(H-2  b, lgh  b)  --  4,900  2,1 O0 
B6  1,200  1,800 
BALB/c  3,700  1,700 
B.C9(H-2  b, Igh  ~)  --  4,700  2,000 
B6  5,000  $00 
BALB/c  5,600  1,800 
BAB. 14(H-2 d  , Igh-V  ~)  --  4,000  1,900 
B6  3,700  2,200 
BALB/c  4,900  400 
C.B20(H-2  d, Igh  b)  --  4,700  1,700 
B6  4,100  1,600 
BALB/c  800  1,800 
BALB/c(H-2  a, Igh  a)  --  4,700  1,800 
B6  3,200  1,600 
BALB/c  4,000  200 
B 10.D2(H-2  a, Igh  b)  --  4,000  2,100 
B6  3,700  1,900 
BALB/c  1,100  1,800 
* l-J molecules were obtained from primary cultures of Ly I T cells, syngeneic Ly2 TsF, 
b  b  and antigen from the given strains.  Haplotype of strains used: B6 (H-2 , Igh ); Balb/ 
c (H-d  d, Igha); B.C9 (H-2b;, Igh*); C.B20 (H-2  d, Ighb), Bab.14 (H-2  d, Igh-C  b Igh-Va); 
d  b  B10.D2 (H-2, Igh ). Supernatants were absorbed with SRBC before being added to 
assay culture. 
* See footnote *, Table I. 
0 Assay cultures contained 2 x  108 Lyl ÷ I-J- T cells, 2 x  I0  ° B cells, Ly2 TsF diluted 
1:5,  and  SRBC.  Boldfaced  numbers  indicate  cultures  in  which  significant  (50%) 
suppression was seen. 
B6  but  not  B.C9  assay  cultures,  while  B.C9  (H-2 b,  Igh  a)  I-J  +  material  with  B6 
Ly2 TsF did not. 
The use of BC.9 mice (H-2 b, Igh  a) confirmed the requirement  for Igh matching 
in the interaction  of the Ly2 TsF I-J  + suppressor complex with its Ta  cell target. 
Combinations  of suppressor  factors  unable  to suppress  B6  cells  (Igh  b) but  fully 
capable of suppressing  the Igh congenic  B.C9 (Igh  a) cells were:  B6 Ly2 TsF with 
B.C9  I-J  +  chain,  BALB/c  Ly2  TsF  with  BAB.14  1-J  +  chain,  and  BALB/c  Ly2 
TsF with  BALB/c  I-J  + chain.  These results are consistent  with  the idea that the 
I-J  + molecule found  in Lyl  cell supernatant  that restores suppressive activities to 1422  INTERACTIONS  IN  LY2  CELL-MEDIATED  SUPPRESSION 
the Ly2 TsF in cultures depleted of the I-J + cells (3) is similar to the molecule 
we find induced by Ly2 TsF in the intermediate culture. 
The I-J + Molecule Induced by Ly2 TsF Cannot Functionally Replace the I-J + Molecule 
in Lyl  TsiF.  Since previous results have shown that a  I-J  + molecule from Lyl 
cell supernatants could mimic the functional activity of I-J  + molecules induced 
by Ly2 TsF (3), it remained to be determined whether the I-J + molecule needed 
for Lyl  TsiF activity was functionally identical to the 1-J  + molecule induced by 
tbe Ly2 TsF in vitro. To solve this dilemma, we reasoned that while immune 
Ly I cell supernatants may contain a great number of l-j+ molecules, I-j  + mole- 
cules induced by Ly2 TsF in vitro may be much more restricted in their activity, 
i.e., may only work with Ly2 TsF to effect suppression on Lyl T  cells. To test 
this  hypothesis,  we asked  whether I-J + molecules induced by  Ly2 TsF  could 
mimic the I-J + molecule needed for Lyl TsiF activity. Lyl TsiF was fractionated 
into antigen-binding and I-J + chains by passage over an anti-I-J immunosorbent, 
and the eluted I-J + molecules were added to either Lyl TsiF I-J- chain or Ly2 
TsF to test for its ability to reconstitute suppressor activity. Likewise, I-J  + material 
induced in primary culture by syngeneic Ly2 TsF was used after absorption with 
antigen to reconstitute Lyl I-J- chain or Ly2 TsF activity. Lyl TsiF activity was 
measured on whole T  plus B cultures, while Ly2 TsF activity was measured on 
Lyl+,2  -  I-J-  T  plus  B  cultures.  The  results,  in  Table  VIII,  shows  that  I-J + 
material  from  either  Lyl  cell  supernatant  or  Ly2  TsF-induced  cultures  can 
restore  Ly2  TsF  activity  (lines  7-9),  but  only  I-J +  material  from  Lyl  cell 
TABLE  Vlll 
IJ* Molecule Induced by Ly-2 TsF Does Not Substitute for the 1-J  +  Molecule Needed 
for Lyl TsiF Activity 
Source of I-J  +  Source of Ag 
molecule*  binding chain* 
Anti-SRBG PFC/cuIture 
Whole  Lyl I-J- 
T  + B  !  T  +  B I 
--  --  3,100  3,300 
Lyl CS  --  2,700  3,400 
Ly-2 TsF induced  --  2,600  2,800 
--  Ly- 1-CS  3,300"*  ND  I 
Lyl CS  Ly-I-CS  1,100  ND 
Ly-2 TsF induced  Ly-I-CS  3,000 ~  ND 
--  Ly-2 TsF  800  3,300 
Lyl CS  Ly-2 TsF  600  1,500 
Ly-2 TsF induced  Ly-2 TsF  500  1,000 
* I-J  + material was either isolated from Lyl cell supernatant (CS) by absorption with 
SRBC or was  made from primary cultures of I~6 Lyl  T  cells, SRBC-specific Ly2 
TsF, and SRBC as detailed in Materials and Methods, 
* SRBC-specific. Ly 1 antigen (Ag) binding chain was obtained by passage of Ly 1TsiF 
over an anti-I-J immunosorbent. 
Assay for Ly 1 TsiF activity. 
I Assay for Ly2 TsF-I-J  + chain activity, 
ND, not done; no suppression expected in these groups. 
** Important negative result showing Lyl  antigen-binding chain does not induce I-J  + 
material needed for Lyl TsiF activity. 
Important negative result showing I-J* chain induced by Ly2 TsF does not work 
with LyI TsiF antigen-binding chain. FLOOD  AND  LOUIE  1423 
supernatants could restore the suppressive activity of Lyl  I-J- antigen-binding 
chain (lines 4-6). Therefore, it appears that while Ly 1 TsiF contains 1-J  + material 
that has more than one activity, the 1-J  + material induced by Ly2 TsF can only 
complement with  Ly2  TsF  for  suppressive activity,  and does not  contain the 
activity necessary to replace the 1-J  + material normally involved in the induction 
of suppression of Lyl TsiF. 
Discussion 
We have previously found a product of hyperimmune Ly2 T  cells (Ly2 TsF) 
to  be  a  one-chain  suppressor  factor  that  is  antigen-specific and  can  directly 
suppress Lyl T  cells (1), so long as these cells share MHC polymorphisms with 
the cells producing the Ly2 TsF. However, the action of this molecule was found 
to be dependent on an intermediary cell, an Ly 1 I-J  + T  cell that was not the final 
target of suppression. The activity of this cell could be functionally replaced by 
the addition of I-J + material secreted by Lyl  T  cells from hyperimmune mice 
(3). The cellular source of this I-J  + material had to share I-J-linked polymorph- 
isms with the cellular source of the Ly2 TsF, and Igh-V-linked polymorphisms 
with the target cells in order to form a  suppressive molecular complex. There- 
fore,  while Ly2 TsF is a  one-chain molecule, the ultimate molecular complex 
that  effects  suppression  is  made up  of two chains:the  Ly2  TsF  and  an  I-J  + 
molecule supplied by the assay population. 
In the present set of experiments, we investigated the mechanism by which 
Ly2 TsF induces production of an I-J  + molecule from the assay population, and 
how these two molecules interact to effect suppression. We found that (a) Ly2 
TsF,  presumably  with the  help of antigen  and  an  I-A  + APC,  induces an  I-J + 
antigen nonspecific molecule from an Lyl I-J + T  cell in the assay population that 
appears to act selectively with the Ly2 TsF molecule; (b) this induction requires 
homology in the IE region of the MHC between cells producing Ly2 TsF and 
those  producing  the  1-J  +  molecule;  (c)  the  interaction  of the  two  molecules 
requires MHC homology and (d) the suppressive complex acts on Lyl+,2 -  I-J- 
T+B cells but changes the genetic homology requirements from the need for 
the cellular source of Ly2 TsF to match the target cells at  MHC-linked poly- 
morphisms to the need for target cells to match the cellular source of the 1-J  + 
chain at  Igh-V linked genes.  Therefore,  the  MHC  restriction  observed using 
Ly2 TsF reflects a  requirement for interaction with the cells providing the 1-J  + 
partner molecule Ly2 TsF requires to effect suppression, and not a  restriction 
in its ability to interact with the final target cell of suppression. The ultimate 
genetic restriction of the suppressor complex of Ly2 TsF and the 1-J  + molecule 
resides strictly in the 1-J  + molecule, and not the Ly2 TsF. 
These results complement and extend our earlier findings that the Ly2 TsF 
requires  two separate  macromolecules to mediate suppressive activity (3).  We 
have been studying two different suppressor factors in our laboratory that also 
require two separate molecules for activity: Ly 1 TsiF (4), an antigen-specific T 
cell factor secreted by  Lyl  T  cells that induces suppressor activity, and TNP- 
TsF  (7),  a  factor that acts  to inhibit the activity of immune Lyl  T  cells that 
transfer contact sensitivity. A  number of other laboratories have also reported 1424  INTERACTIONS  IN  LY2  CELL-MEDIATED  SUPPRESSION 
two-chain antigen-specific suppressor factors, including Taniguchi et al. (8), and 
Taussig and Holliman (9). 
Since it is clear that the Ly2 TsF molecular complex is composed of two chains, 
there is some question as to which molecule contains the suppressive information. 
We believe that the functional suppressor information is on the antigen-binding 
molecule of the Ly2 TsF.  There are two main reasons for this assignment: (a) 
Fresno et al. (10,  11) have shown that function suppressor activity resides in the 
C terminal piece of the antigen-binding chain of a clonal T  suppressor effector 
factor; and (b) we have shown that an artificially constructed molecular hybrid 
complex consisting of antigen-binding Ly2 TsF and the B chain of cholera toxin 
(the cholera toxin molecule consists of two chains with the A  chain containing 
the functionally active site while B chain serves as the schlepper molecule (12)) 
can suppress  lymphoid cells that  express  GM-1,  the cell surface receptor for 
cholera toxin B chain (Wang et al., manuscript in preparation). This functional 
similarity  between  cholera  toxin  B  chain  and  the  I-J  +  molecule is  especially 
intriguing  since  it  assumes  a  focusing  function  for  the  I-J  +  molecule.  This 
similarity may help to explain the mechanism of recognition and internalization 
of the suppressive moiety of this suppressor complex and help us to form a model 
for suppressor factor activity that may be a biological generalization. 
The initial event is the antigen-dependent induction of I-J  + molecules by the 
antigen-binding piece of the Ly2 TsF.  The induction of factors in suppressor 
circuits by other factors has been previously described (13). In these experiments, 
TsF factors can be induced by in  vitro immunization with Tsl  factors in  the 
absence of antigen. The fact that antigen is required in our system suggests that 
antigen may play an important role in "activating" the TsF to initiate the cellular 
interaction. The antigen-activated TsF then induces an I-J  + cell to secrete a cell- 
free product that functionally replaces the activity of this cell.  This induction 
process  also  requires  the  presence  of a  cell  that  is  I-A  +,  Ig-,  and  Thy-1-. 
Previously, investigators have found that I-J (14-17) and I-C (18) regions restrict 
the induction of various cell types in suppressor cell circuits, while I-A and I-E 
gene products have been primarily in the induction of T  helper cells (19). The 
finding of I-A  + and I-E  + cells involved in  the induction of certain cells in the 
suppressor circuit may represent the involvement of these certain cell types both 
in the induction of helper and suppressor T  cell subsets.  Recently, Habu et ai. 
(20),  found an I-J  +,  I-A  +, I-E  + non-T, non-B cell was required for the in vitro 
response  of normal  spleen  cells  to  SRBC.  It  is  quite  possible  that  this  cell, 
presumably an APC, may also be required for transducing suppressor cell signals. 
Recently Minami et ai.  reported  that  I-J  + cells,  which they call  FPC  (factor- 
presenting cells), are involved in the induction of various cells in their suppressor 
circuit (21).  Experiments are currently underway to delineate the involvement 
of different cell types in the induction of the I-J  + molecule by Ly2 TsF. 
The nature of the interactions involved in the induction of the I-J  + molecule 
is  currently unknown,  but  almost certainly involves the recognition of a  cell 
surface molecule on the surface of the Lyl I-J  + cell. This recognition, presumably 
by the Ly2 TsF, results in the activation of this cell to begin secreting a molecule 
that now works in consort with the Ly2 TsF to mediate antigen-specific suppres- 
sion.  This molecular interaction may involve an  I-J and anti-I-J like immune FLOOD  AND  LOUIE  1425 
reaction. In any case, the functionally active molecular complex can then interact 
with its target cell and deliver the signal carried by the functionally suppressive 
antigen-binding chain.  The focusing event mediated by the I-J + chain and the 
target  cell receptor is influenced by  Igh-V-linked genes.  This places the  H-2 
restriction of the Ly2 TsF on the induction and interaction with the I-J  + molecule, 
and the subsequent Igh-V restriction on the interaction of the schlepper molecule 
with its target cell. 
It therefore appears that while the Ly2 TsF under the appropriate conditions 
has potent suppressor activity, it also has the ability to induce a  cell activity as 
well, namely the production of I-J  + chain production, depending on which cell 
this factor interacts with. Although it remains to be determined whether it is the 
same molecule that induces the I-J + chain production that later works in tandem 
with such molecules to effect suppression, an interesting mechanism may be at 
work here: a single molecular entity may have both an inducing and suppressing 
activity depending upon the  target  cell.  It remains to be  seen whether other 
suppressor-effector  molecules work  in a  fashion  similar to  the  one  described 
here. 
While  these  experiments  raise  a  number  of important questions about  the 
nature of cellular interactions in the suppressor circuit, even more perplexing 
problems are raised about the nature of the genetic restrictions exhibited by cell- 
free suppressor factors:  (a) what is the nature of the genetic restriction of the 
induction of the I-J + molecule by Ly2 TsF, while subsequent functional interac- 
tion between these two molecules is I-J restricted? Our results suggest that the 
genetic restriction maps to the I-E subregion of the MHC. What is the relationship 
between I-J and IE determinants, if any?; (b) where is the structural gene for the 
Ly2 TsF coded, and how does a  single molecular entity contain specificity for 
antigen and MHC region restrictions? and (c) how does a  product of the  17th 
chromosome get onto a  molecule with structural gene products from the  12th 
chromosome (22), as is the case with the I-J  + schlepper under investigation? 
In conclusion, we would like to put forth the notion that the molecular complex 
that effects suppression in this system has seven functionally active molecular 
sites (Fig. 1): (a) the MHC restricting element on Ly2 TsF that interacts with the 
IA  ÷  APC;  (b)  the  inducing  site  on  Ly2  TsF  for  the  I-J  +  molecule;  (c)  the 
suppressive moiety on the Ly2 antigen-binding TsF; (d) the I-J + determinant on 
the schlepper molecule; (e) the anti-I-J receptor on the Ly2 TsF, which imparts 
an I-J subregion genetic restriction on the interaction of Ly2 TsF and the I-J + 
molecule; (f) the Igh-V restricting element on the I-J + schlepper chain; and (g) 
the antigen-binding receptor on the Ly2 TsF, which imparts antigen specificity 
to the factor. These seven sites must work in consort to form an antigen-specific 
suppressor effector molecule. 
Summary 
A cell-free product secreted by Lyl-2 ÷ T  cells (Ly2 TsF) can suppress the in 
vitro response to sheep erythrocytes (SRBC) of spleen cells depleted of Ly2  + T 
cells. This suppressor factor expresses biological activity only when the acceptor 
cells share major histocompatibility complex (MHC)-linked polymorphic genes 
with the cells that made the Ly2 TsF.  Removal of Ly t  I-J  + cells from the assay 1426 
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1.  Seven active sites involved in the suppressive effects of Ly2TsF (see Discussion). 
culture abrogates the ability of Ly2 TsF to suppress these cultures, but we can 
replace the need for the I-J  + cells in the assay culture with an I-J  + soluble factor 
derived from them.  We investigated the celtuiar interactions involved in  the 
activation of I-J  + cells by Ly2 TsF in  vitro.  We have been able to induce the 
production of an I-J + molecule needed for Ly2 TsF activity in a 48-h intermediate 
culture of B ceil-depleted Lyl spleen cells, Ly2 TsF, and antigen. This molecule 
not only fails to bind antigen, but is also antigen nonspecific in that it can be 
induced by Ly2 TsF of irrelevant specificities. In order to replace the activity of 
the Lyl I-J  + cell in the assay culture, the cell induced by Ly2 TsF to produce the 
I-J  + molecule in vitro must share genetic polymorphisms linked to the MHC with 
the Ly2 TsF, and genetic polymorphisms linked to the Igh-V gene complex with 
the target cell. In order for Ly2 TsF to induce cells of the primary culture to 
produce the I-J  + molecule, Ly2 TsF must share genetic polymorphisms linked to 
the IE region of the MHC with the Lyl I-J  + cell producing the I-J  + molecule. 
These results indicate that the suppressive mechanism of Ly2 TsF involves the 
interaction with an  Lyl  I-J  + molecule. This  I-J  + molecule serves to  focus the 
antigen-specific suppressor molecule on the target cell. The recognition event of 
this suppressive complex on the surface of the acceptor cell is controlled by Igh- 
V-linked genes restricted by the I-J  + molecule of the suppressor complex. This 
suppressor interaction is confined to the suppressor effector phase of the sup- 
pressor circuit since the I-J  + molecules needed for by Ly2 TsF activity do not 
substitute for the I-J  + molecules needed for the activity of LyI  TsiF, a  T  cell FLOOD AND  LOUIE  1427 
factor that initiates the suppressor cell circuit. Thus, two distinct I-J  + Ly  I  cell- 
derived molecules, each carrying VH-linked genetic restrictions, must exist in the 
suppressor circuit. 
Received for publication 20 December 1983. 
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